StonvexLoading…
StonvexStonvexStonvexCore line items from RDCM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $61.01M | $51.60M | $46.05M | $40.28M |
Operating Income | $3.09M | $-662.00K | $-4.11M | $-5.49M |
Net Income | $6.97M | $3.71M | $-2.26M | $-5.26M |
EPS (Diluted) | $0.43 | $0.24 | $-0.16 | $-0.37 |
Total Assets | $130.57M | $107.53M | $101.00M | $91.66M |
Total Liabilities | $34.90M | $25.04M | $28.22M | $21.51M |
Cash & Equivalents | $19.24M | $10.89M | $9.53M | $11.95M |
Free Cash Flow OCF − CapEx | $10.96M | $4.47M | $5.87M | $1.56M |
Shares Outstanding | 15.92M | 15.31M | 14.74M | 14.16M |